Search Results - "Park, Jason Y."

Mass Spectrometry for COVID-19 by SoRelle, Jeffrey A, Patel, Khushbu, Filkins, Laura, Park, Jason Y

“…In the United States, response to the COVID-19 coronavirus pandemic has been hampered by inadequate testing resources for the causative virus SARS-CoV-2. In…”
Get full text

Trends in the US and Canadian Pathologist Workforces From 2007 to 2017 by Metter, David M, Colgan, Terence J, Leung, Stanley T, Timmons, Charles F, Park, Jason Y

“…The current state of the US pathologist workforce is uncertain, with deficits forecast over the next 2 decades. To examine the trends in the US pathology…”
Get full text

Laboratory Action Plan for Emerging SARS-CoV-2 Variants by Filkins, Laura, SoRelle, Jeffrey A, Schoggins, John, Park, Jason Y

Get full text

JAK-STAT6 Pathway Inhibitors Block Eotaxin-3 Secretion by Epithelial Cells and Fibroblasts from Esophageal Eosinophilia Patients: Promising Agents to Improve Inflammation and Prevent Fibrosis in EoE by Cheng, Edaire, Zhang, Xi, Wilson, Kathleen S, Wang, David H, Park, Jason Y, Huo, Xiaofang, Yu, Chunhua, Zhang, Qiuyang, Spechler, Stuart J, Souza, Rhonda F

“…Although most studies on treatments for eosinophilic esophagitis (EoE) have focused on effects in the epithelium, EoE is a transmural disease. Eosinophils that…”
Get full text

Review of autoimmune metaplastic atrophic gastritis by Park, Jason Y., MD, PhD, Lam-Himlin, Dora, MD, Vemulapalli, Roopa, MD

Get full text

Prospects for the commercialization of chemiluminescence-based point-of-care and on-site testing devices by Park, Jason Y., Kricka, Larry J.

“…Chemiluminescent reactions have found application in a number of commercial point-of-care and on-site testing devices. Notable examples include allergy tests…”
Get full text

Molecular signatures of pancreatic cancer by Hong, Seung-Mo, Park, Jason Y, Hruban, Ralph H, Goggins, Michael

“…The introduction of genome- and epigenome-wide screening techniques has dramatically improved our understanding of the molecular mechanisms underlying the…”
Get full text

Helicobacter pylori Clarithromycin Resistance and Treatment Failure Are Common in the USA by Park, Jason Y., Dunbar, Kerry B., Mitui, Midori, Arnold, Christina A., Lam-Himlin, Dora M., Valasek, Mark A., Thung, Irene, Okwara, Chinemerem, Coss, Elizabeth, Cryer, Byron, Doern, Christopher D.

“…Background Helicobacter pylori antibiotic resistance leads to frequent treatment failure. However, the current US prevalence of H. pylori clarithromycin…”
Get full text

Maximum dose, safety, tolerability and ketonemia after triheptanoin in glucose transporter type 1 deficiency (G1D) by Málaga, Ignacio, Avila, Adrian, Primeaux, Sharon, Kallem, Raja Reddy, Roe, Charles R., Putnam, William C., Park, Jason Y., Shinnar, Shlomo, Ahn, Chul, Pascual, Juan M.

“…Augmentation of anaplerosis, or replenishment of carbon lost during intermediary metabolic transitions, is desirable in energy metabolism defects…”
Get full text

Cytoplasmic RNA quality control failure engages mTORC1-mediated autoinflammatory disease by Yang, Kun, Han, Jie, Asada, Mayumi, Gill, Jennifer G, Park, Jason Y, Sathe, Meghana N, Gattineni, Jyothsna, Wright, Tracey, Wysocki, Christian A, de la Morena, M Teresa, Garza, Luis A, Yan, Nan

“…Inborn errors of nucleic acid metabolism often cause aberrant activation of nucleic acid sensing pathways, leading to autoimmune or autoinflammatory diseases…”
Get full text

Combination of triheptanoin with the ketogenic diet in Glucose transporter type 1 deficiency (G1D) by Avila, Adrian, Málaga, Ignacio, Sirsi, Deepa, Kayani, Saima, Primeaux, Sharon, Kathote, Gauri A., Jakkamsetti, Vikram, Kallem, Raja Reddy, Putnam, William C., Park, Jason Y., Shinnar, Shlomo, Pascual, Juan M.

“…Fuel influx and metabolism replenish carbon lost during normal neural activity. Ketogenic diets studied in epilepsy, dementia and other disorders do not…”
Get full text

Mycophenolic Acid (Cellcept and Myofortic) Induced Injury of the Upper GI Tract by NGUYEN, Thong, PARK, Jason Y, SCUDIERE, Jennifer R, MONTGOMERY, Elizabeth

“…Mycophenolic acid (MPA) is an immunosuppressant drug commonly used in patients undergoing solid organ transplant. Although its pattern of inducing injury in…”
Get full text

Distinct autoantibody profiles across checkpoint inhibitor types and toxicities by Mu-Mosley, Hong, von Itzstein, Mitchell S, Fattah, Farjana, Liu, Jialiang, Zhu, Chengsong, Xie, Yang, Wakeland, Edward K, Park, Jason Y, Kahl, Brad S, Diefenbach, Catherine S, Gerber, David E

“…Immune checkpoint inhibitors (ICI) are increasingly used in combination. To understand the effects of different ICI categories, we characterized changes in…”
Get full text

Proton pump inhibitors decrease eotaxin-3 expression in the proximal esophagus of children with esophageal eosinophilia by Park, Jason Y, Zhang, Xi, Nguyen, Nathalie, Souza, Rhonda F, Spechler, Stuart J, Cheng, Edaire

“…Besides reducing gastric acid secretion, proton pump inhibitors (PPIs) suppress Th2-cytokine-stimulated expression of an eosinophil chemoattractant (eotaxin-3)…”
Get full text

Cachexia, chorea, and pain in chronic nonbacterial osteitis and inflammatory bowel disease: a case report by Agharokh, Ladan, Mamola, Katherine, Yu, Andrew G, Medina, Annette L, Gurram, Bhaskar, Fuller, Julie, Park, Jason Y, Chen, Weina, Rajaram, Veena, Hammer, Matthew R, Waugh, Jeff L

“…Inflammatory bowel disease is an inflammatory disorder that primarily impacts the gastrointestinal tract, leading to malnutrition and chronic microscopic…”
Get full text

A Biopython-based method for comprehensively searching for eponyms in Pubmed by Cornish, Toby C., Kricka, Larry J., Park, Jason Y.

“…Eponyms are common in medicine; however, their usage has varied between specialties and over time. A search of specific eponyms will reveal the frequency of…”
Get full text

SCGN deficiency results in colitis susceptibility by Sifuentes-Dominguez, Luis F, Li, Haiying, Llano, Ernesto, Liu, Zhe, Singla, Amika, Patel, Ashish S, Kathania, Mahesh, Khoury, Areen, Norris, Nicholas, Rios, Jonathan J, Starokadomskyy, Petro, Park, Jason Y, Gopal, Purva, Liu, Qi, Tan, Shuai, Chan, Lillienne, Ross, Theodora, Harrison, Steven, Venuprasad, K, Baker, Linda A, Jia, Da, Burstein, Ezra

“…Inflammatory bowel disease (IBD) affects 1.5-3.0 million people in the United States. IBD is genetically determined and many common risk alleles have been…”
Get full text

Association between body mass index, dosing strategy, and efficacy of immune checkpoint inhibitors by Ahmed, Murtaza, von Itzstein, Mitchell S, Sheffield, Thomas, Khan, Shaheen, Fattah, Farjana, Park, Jason Y, Popat, Vinita, Saltarski, Jessica M, Gloria-McCutchen, Yvonne, Hsiehchen, David, Ostmeyer, Jared, Khan, Saad A, Sultana, Nazima, Xie, Yang, Li, Quan-Zhen, Wakeland, Edward K, Gerber, David E

“…BackgroundIncreased body mass index (BMI) has been associated with improved response to immune checkpoint inhibitors (ICIs) in multiple cancer types. We…”
Get full text

T-cell tolerant fraction as a predictor of immune-related adverse events by Ostmeyer, Jared, Park, Jason Y, von Itzstein, Mitchell S, Hsiehchen, David, Fattah, Farjana, Gwin, Mary, Catalan, Rodrigo, Khan, Shaheen, Raj, Prithvi, Wakeland, Edward K, Xie, Yang, Gerber, David E

“…Immune checkpoint inhibitor (ICI) therapies may cause unpredictable and potentially severe autoimmune toxicities termed immune-related adverse events (irAEs)…”
Get full text

Novel Helicobacter pylori Sequencing Test Identifies High Rate of Clarithromycin Resistance by Mitui, Midori, Patel, Ashish, Leos, N. Kristine, Doern, Christopher D., Park, Jason Y.

“…ABSTRACT Objectives: Eradication therapy selection for Helicobacter pylori gastritis requires knowledge of the local resistance rate to clarithromycin. There…”
Get full text